Advertisement

The Latest

MiMedx, a developer of biomaterial-based products and bioimplants, has posted $1.04 million in total revenue for the first quarter of FY 2011, representing an 808 percent increase compared to $114,900 in revenue for the first quarter of last year, according…

Advertisement